top of page
Hope4ATRT_Logo_small.png

We know that navigating a diagnosis like ATRT comes with a lot of questions. One of the most powerful ways families can help drive progress and gain expert insight is by joining the PNOC030 ATRT Registry.


What is it? The registry is a specialized study designed to collect data, imaging, and (optional) samples from children with ATRT. It helps the world’s leading researchers at PNOC (Pacific Pediatric Neuro-Oncology Consortium) better understand the molecular subgroups of this disease.


Why is it important?

Data is the key to a cure, but joining also provides an incredible resource for your family:

  • Driving Progress: Your child’s journey contributes to a global database that helps doctors find more effective, less toxic treatments. It’s a way to ensure every warrior’s story helps light the path for the next.

  • Expert Review: By participating, your family gains access to PNOC’s ATRT Tumor Board, where a panel of world-class specialists can review your child’s case and provide treatment recommendations.


How do I join? 

  1. Check Your Site: Visit pnoc.us/pnoc030 to see if your hospital is a PNOC institution.

  2. Confirm the Details: In your email, mention where your child is being treated and if you have a pathology report with a molecular subgroup listed (MYC, TYR, or SHH).

  3. Connect with the Team: You’ll schedule a quick consent conference with the program manager to review the documents and choose your options for sample sharing and tumor board review.

  4. Let them do the heavy lifting: Once you’ve consented, the team coordinates with your hospital to collect medical records and imaging.


Your participation fuels the search for a cure.



Infographic for PNOC's ATRT Registry with DNA graphic, icons of research, family, expertise, and text: "Your story fuels the search."

 
 

We are thrilled to share some "Hot off the Press" news that brings a fresh wave of hope to our community. Lantern Pharma and Starlight Therapeutics have just received FDA clearance to begin a Phase 1 clinical trial for a promising new drug combination, STAR-001, specifically for pediatric patients with CNS tumors like ATRT.


What is this trial different?

🧬 The Double-Whammy Strategy: The trial tests a combination of STAR-001 and a common medication called spironolactone.

🧬 The "Synthetic Lethality" Approach: STAR-001 creates damage inside the cancer cell’s DNA. Normally, the cell tries to repair that damage to survive. Spironolactone acts as the "lock," breaking the cell's repair machinery so the cancer cannot fix itself.

🧬 Promising Preclinical Results: In laboratory models of ATRT, this specific combination extended survival by 181% compared to the control groups.


Who is involved?

This trial will be conducted through POETIC, a prestigious consortium of 14 leading children's cancer centers across the US, Canada, and Israel.


What this means for our families

As Lantern Pharma’s CEO, Panna Sharma, put it: For children with relapsed or refractory CNS tumors, the options are desperately limited — and the science behind this planned trial was built to change that."


This milestone represents a genuinely new way to attack these tumors by exploiting their biological vulnerabilities.


Check out the full press release: https://bit.ly/4sNLNqY


 
 
Fundraiser t-shirt for ATRT awareness, featuring the inspiring phrase 'Little Fighters, Big Hope' and a subtle design. Various styles and colors are available on Bonfire.

You can now show your support and help spread awareness by purchasing items from our new collection, including shirts and sweatshirts in a variety of styles and colors!

➡️ Shop the "Little Fighters, Big Hope" collection here: bonfire.com/hope4atrt/


OR, make it personal! If you're looking for a unique way to make an impact, you can also start your own shirt fundraiser! Customize the design with your warrior's name to rally your community and raise even more vital funds.

➡️ Launch your customized fundraiser here: bonfire.com/event/hope4-atrt/


Thank you for being a part of our mission and helping us create a brighter future for children fighting ATRT. Your support makes a world of difference!


 
 

Hope4ATRT Foundation

is a research entity of Out of Zion, Inc.

IRS Code: Section 501(c)(3). Tax ID #81-5022992

Mailing Address: 

PO Box 46713

Tampa, FL  33646

bottom of page